Development of novel monoclonal antibodies against nsp12 of SARS-CoV-2

A novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has caused a global pandemic of coronavirus disease 19. Coronaviruses, including SARS-CoV-2, use RNA-dependent RNA polymerase (RdRP) for viral replication and transcription. Since RdRP is a promising therapeutic targe...

Descripción completa

Detalles Bibliográficos
Autores principales: Machitani, Mitsuhiro, Takei, Junko, Kaneko, Mika K., Ueki, Saori, Ohashi, Hirofumi, Watashi, Koichi, Kato, Yukinari, Masutomi, Kenkichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9736705/
https://www.ncbi.nlm.nih.gov/pubmed/36496472
http://dx.doi.org/10.1186/s12985-022-01948-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9736705/
https://www.ncbi.nlm.nih.gov/pubmed/36496472
http://dx.doi.org/10.1186/s12985-022-01948-2

Ejemplares similares